AR001078A1 - Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración - Google Patents

Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración

Info

Publication number
AR001078A1
AR001078A1 AR33528896A AR33528896A AR001078A1 AR 001078 A1 AR001078 A1 AR 001078A1 AR 33528896 A AR33528896 A AR 33528896A AR 33528896 A AR33528896 A AR 33528896A AR 001078 A1 AR001078 A1 AR 001078A1
Authority
AR
Argentina
Prior art keywords
collagenase
wounds
transfer
pharmaceutical form
procedure
Prior art date
Application number
AR33528896A
Other languages
English (en)
Inventor
Michael Roreger
Heinz Dr Einig
Original Assignee
L T S Lohmann Therapie Systeme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L T S Lohmann Therapie Systeme filed Critical L T S Lohmann Therapie Systeme
Publication of AR001078A1 publication Critical patent/AR001078A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Una forma farmacéutica destinada a la cesión de colagenasa en heridas se caracteriza por la combinación de las siguientes propiedades: a) es coherente,de forma plana, y conformable; b) es de igual o menor tamano que la superficie de la herida at ratar; c) contiene colagenasa en cantidades definidas ydistribuida homogéneamente; d)está conformada para una liberación controlada de la colagenasa.
AR33528896A 1995-02-02 1996-02-12 Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración AR001078A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503338A DE19503338C2 (de) 1995-02-02 1995-02-02 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
AR001078A1 true AR001078A1 (es) 1997-09-24

Family

ID=7752981

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33528896A AR001078A1 (es) 1995-02-02 1996-02-12 Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración

Country Status (27)

Country Link
US (1) US6074664A (es)
EP (1) EP0809489B1 (es)
JP (1) JP2000515485A (es)
KR (1) KR19980701888A (es)
CN (1) CN1182364A (es)
AR (1) AR001078A1 (es)
AT (1) ATE201136T1 (es)
AU (1) AU707364B2 (es)
BG (1) BG101802A (es)
BR (1) BR9606997A (es)
CA (1) CA2212059A1 (es)
CZ (1) CZ290943B6 (es)
DE (2) DE19503338C2 (es)
DK (1) DK0809489T3 (es)
ES (1) ES2159013T3 (es)
FI (1) FI972949A (es)
GR (1) GR3036384T3 (es)
HU (1) HUP0202088A2 (es)
MX (1) MX9705806A (es)
NO (1) NO973525D0 (es)
NZ (1) NZ300202A (es)
PL (1) PL182849B1 (es)
PT (1) PT809489E (es)
SK (1) SK282578B6 (es)
TR (1) TR199700734T1 (es)
WO (1) WO1996023487A1 (es)
ZA (1) ZA96795B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
DE19829789A1 (de) * 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US7632494B2 (en) * 1999-09-24 2009-12-15 Proteon Therapeutics, Inc. Methods for enlarging the diameter of a biological conduit in a human subject
US7063838B1 (en) * 1999-09-24 2006-06-20 Proteon Therapeutics Llc Methods for treating an artery or vein in a human subject
US6756051B1 (en) * 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
DE10117916C2 (de) * 2001-04-10 2003-03-20 Christa Stolz Faltbares mit Creme beschichtetes Folienelement (Folienschuh) zur hygienischen Aufbringung von Fußcreme bei der Anwendung von mechanischen Fußmassagevorrichtungen
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
US9694100B2 (en) * 2009-12-08 2017-07-04 Smith & Nephew, Inc. Enzymatic wound debriding compositions with enhanced enzymatic activity
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
US10137179B2 (en) 2016-05-18 2018-11-27 Hyalo Technologies, LLC Composition and method of preparation of protease microparticulate slow release preparation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2432925C3 (de) * 1974-07-05 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen Folienförmige Arzneimittel
FR2488797A1 (fr) * 1980-08-19 1982-02-26 Lhd Lab Hygiene Dietetique Composition dermatologique, son procede de preparation et son application dans le domaine des pansements
ZA818919B (en) * 1981-04-13 1982-11-24 Seton Co Cosmetic and pharmaceutical sheet material containing polypeptides
DE3139089A1 (de) * 1981-10-01 1983-04-14 Röhm Pharma GmbH, 6100 Darmstadt Flaechengebilde auf proteinbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
CA1256772A (en) * 1985-02-26 1989-07-04 Sudhakar S. Wagle Bandage for the topical administration of controlled amounts of nitroglycerin ointment
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
DE3606265A1 (de) * 1986-02-27 1987-09-03 Roehm Pharma Gmbh Wundauflage auf polysaccharidbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme und mit hoher saugfaehigkeit
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
DE8709810U1 (de) * 1987-07-16 1987-10-08 E.R. Squibb & Sons, Inc., Princeton, N.J. Medizinisches Pflaster
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5206026A (en) * 1988-05-24 1993-04-27 Sharik Clyde L Instantaneous delivery film
DE8902311U1 (de) * 1989-02-27 1989-05-11 Berg, Heide von, 8000 München Heilpflaster
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
DE4230589C1 (de) * 1992-09-12 1994-02-03 Lohmann Therapie Syst Lts Dosierverfahren für leicht flüchtige oder thermolabile Substanzen in flüssiger Form zur Herstellung von u.a. flächigen Arzneiformen, insbesondere zur Herstellung von transdermalen oder dermalen therapeutischen Systemen
IL104734A0 (en) * 1993-02-15 1993-06-10 Univ Bar Ilan Bioactive conjugates of cellulose with amino compounds

Also Published As

Publication number Publication date
DE19503338A1 (de) 1996-08-08
BR9606997A (pt) 1997-10-28
EP0809489B1 (de) 2001-05-16
MX9705806A (es) 1998-07-31
SK101597A3 (en) 1998-04-08
EP0809489A1 (de) 1997-12-03
NO973525L (no) 1997-07-31
FI972949A (fi) 1997-08-28
CA2212059A1 (en) 1996-08-08
PL321810A1 (en) 1997-12-22
HUP0202088A2 (en) 2002-09-28
ATE201136T1 (de) 2001-06-15
SK282578B6 (sk) 2002-10-08
FI972949A0 (fi) 1997-07-11
US6074664A (en) 2000-06-13
WO1996023487A1 (de) 1996-08-08
DE59606907D1 (de) 2001-06-21
GR3036384T3 (en) 2001-11-30
ES2159013T3 (es) 2001-09-16
JP2000515485A (ja) 2000-11-21
CN1182364A (zh) 1998-05-20
KR19980701888A (ko) 1998-06-25
PT809489E (pt) 2001-10-31
CZ221997A3 (en) 1997-12-17
NZ300202A (en) 1999-10-28
AU707364B2 (en) 1999-07-08
NO973525D0 (no) 1997-07-31
TR199700734T1 (xx) 1998-02-21
AU4487396A (en) 1996-08-21
DE19503338C2 (de) 1998-07-30
BG101802A (en) 1998-02-27
CZ290943B6 (cs) 2002-11-13
DK0809489T3 (da) 2001-09-10
PL182849B1 (pl) 2002-03-29
ZA96795B (en) 1996-07-16

Similar Documents

Publication Publication Date Title
AR001078A1 (es) Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración
ATE187887T1 (de) Verzögerte freigabe matrix für arzneimittel
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
ES2053206T3 (es) Composiciones de liberacion retardada.
ES2054680T3 (es) Aposito para heridas y su preparacion y uso.
DK0810856T3 (da) Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse
DE69739656D1 (de) 1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
AR033796A1 (es) Composicion farmaceutica
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
ES2182874T3 (es) Procedimiento de tratamiento de las uñas.
ES2151150T3 (es) Preparados transparentes de rapida liberacion, de analgesicos no esteroidales.
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
DK0759687T3 (da) Anvendelse af gelpræparater som bejdsemidler
CO5631449A2 (es) Nuevos esteres de etonogestrel
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
ES2095760T3 (es) Composicion de agente tensioactivo que contiene un agente tensioactivo de sulfato de eter de alquilo de polioxietileno de sodio y un agente tensioactivo de sulfosuccinato.
CO4940373A1 (es) Producto cosmetico para la remocion de tapones queratoticos de poros de la piel
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ATE353639T1 (de) In-vitro-verwendung von astaxanthin zur vorbehandlung von zellen vor uv-bestrahlung zwecks hemmung der aktivierung von nf-kb
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
BR9606955A (pt) Heterocicloalquenos substituísos
TR200001075T2 (tr) Tiamfenikol ve diklofenak içeren bileşimler.
BR7904458A (pt) Composicao para uso em isca para o combate as moscas sinantropas,processo de obtencao da isca e sua utilizacao
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
EP0855191A3 (en) Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent

Legal Events

Date Code Title Description
FB Suspension of granting procedure